Wikidata entity: Q213511
C₃₇H₆₇NO₁₃ (P274)
Quantities
| P2067 | mass | 733.461 |
| P3780 | active ingredient in | ... | Q47521563 (EryPed) | EryPed |
| P3780 | active ingredient in | ... | Q47521564 (Ery-Tab) | Ery-Tab |
| P3780 | active ingredient in | ... | Q47521565 (Erygel) | Erygel |
| P3780 | active ingredient in | ... | Q47521566 (Erythrocin) | Erythrocin |
| P3780 | active ingredient in | ... | Q47521567 (Erythrocin Stearate) | Erythrocin Stearate |
| P3780 | active ingredient in | ... | Q48826381 (PCE) | PCE |
| P3780 | active ingredient in | ... | Q48826422 (Ery) | Ery |
| P3780 | active ingredient in | ... | Q48826464 (Emcin Clear) | Emcin Clear |
| P3780 | active ingredient in | ... | Q48828846 (Emgel) | Emgel |
| P3780 | active ingredient in | ... | Q48829307 (E.E.S.) | E.E.S. |
| P1716 | brand | ... | Q47521566 (Erythrocin) | Erythrocin |
| P233 | canonical SMILES | String | CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O | ??? |
| P373 | Commons category | String | Erythromycin | ??? |
| P703 | found in taxon | ... | Q131238 (Bacillus subtilis) | Bacillus subtilis |
| P703 | found in taxon | ... | Q22286833 (Streptomyces albidoflavus) | Streptomyces albidoflavus |
| P703 | found in taxon | ... | Q25834677 (Aeromicrobium erythreum) | Aeromicrobium erythreum |
| P703 | found in taxon | ... | Q26291044 (Streptomyces lydicus) | Streptomyces lydicus |
| P703 | found in taxon | ... | Q842207 (Pseudoalteromonas) | Pseudoalteromonas |
| P703 | found in taxon | ... | Q2355919 (Streptomyces coelicolor) | Streptomyces coelicolor |
| P703 | found in taxon | ... | Q3975996 (Streptomyces hygroscopicus) | Streptomyces hygroscopicus |
| P703 | found in taxon | ... | Q7396613 (Saccharopolyspora erythraea) | Saccharopolyspora erythraea |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P366 | has use | ... | Q12187 (antibiotic) | antibiotic |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P2175 | medical condition treated | ... | Q79928 (acne) | acne |
| P2175 | medical condition treated | ... | Q101896 (gonorrhea) | gonorrhea |
| P2175 | medical condition treated | ... | Q31798 (chancroid) | chancroid |
| P2175 | medical condition treated | ... | Q129104 (anthrax) | anthrax |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q134859 (pertussis) | pertussis |
| P2175 | medical condition treated | ... | Q154882 (legionnaires' disease) | legionnaires' disease |
| P2175 | medical condition treated | ... | Q156103 (gastroenteritis) | gastroenteritis |
| P2175 | medical condition treated | ... | Q153356 (chlamydia infection) | chlamydia infection |
| P2175 | medical condition treated | ... | Q683861 (campylobacteriosis) | campylobacteriosis |
| P2175 | medical condition treated | ... | Q939261 (erythrasma) | erythrasma |
| P2175 | medical condition treated | ... | Q1122485 (urethritis) | urethritis |
| P129 | physically interacts with | ... | Q24770266 (taste receptor type 2) | taste receptor type 2 |
| P129 | physically interacts with | ... | Q12746111 (Motilin receptor) | Motilin receptor |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q420054 (topical medication) | topical medication |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q32089 (sirolimus) | sirolimus |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q319877 (alprazolam) | alprazolam |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q189522 (quinine) | quinine |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q27139135 (dasatinib monohydrate) | dasatinib monohydrate |
| P769 | significant drug interaction | ... | Q47495785 (theophylline monohydrate) | theophylline monohydrate |
| P769 | significant drug interaction | ... | Q191521 (sildenafil) | sildenafil |
| P769 | significant drug interaction | ... | Q412327 (nilotinib) | nilotinib |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422212 (budesonide) | budesonide |
| P769 | significant drug interaction | ... | Q419186 (ergotamine) | ergotamine |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q420323 (lapatinib) | lapatinib |
| P769 | significant drug interaction | ... | Q420644 (felodipine) | felodipine |
| P769 | significant drug interaction | ... | Q421136 (sorafenib) | sorafenib |
| P769 | significant drug interaction | ... | Q422585 (lopinavir) | lopinavir |
| P769 | significant drug interaction | ... | Q422654 (saquinavir) | saquinavir |
| P769 | significant drug interaction | ... | Q417542 (sunitinib) | sunitinib |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q668093 (atorvastatin) | atorvastatin |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q736270 (mefloquine) | mefloquine |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q894611 (bosutinib) | bosutinib |
| P769 | significant drug interaction | ... | Q907104 (ranolazine) | ranolazine |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q3896970 (pasireotide) | pasireotide |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q1240093 (pravastatin) | pravastatin |
| P769 | significant drug interaction | ... | Q3993743 ((Z)-Toremifene) | (Z)-Toremifene |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q424161 (vardenafil) | vardenafil |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424312 (tolterodine) | tolterodine |
| P769 | significant drug interaction | ... | Q1257318 (bedaquiline) | bedaquiline |
| P769 | significant drug interaction | ... | Q7131441 (panobinostat) | panobinostat |
| P769 | significant drug interaction | ... | Q7157043 (pazopanib) | pazopanib |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P769 | significant drug interaction | ... | Q21011224 (eliglustat) | eliglustat |
| P769 | significant drug interaction | ... | Q21011233 (ceritinib) | ceritinib |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P769 | significant drug interaction | ... | Q471763 (aminophylline) | aminophylline |
| P3364 | stereoisomer of | ... | Q105275114 ((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione) | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| P279 | subclass of | ... | Q74640518 (erythromycin) | erythromycin |
| P279 | subclass of | ... | Q422687 (macrolides) | macrolides |
| P2868 | subject has role | ... | Q12187 (antibiotic) | antibiotic |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q50377202 (gastrointestinal agent) | gastrointestinal agent |
| P2868 | subject has role | ... | Q7251505 (protein synthesis inhibitor) | protein synthesis inhibitor |
| P12081 | WHO Aware Classification | ... | Q122925721 (watch) | watch |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | erythromycin | ??? |
Why not click here or view trends?
log id: 2789145